Vimab Group AB (publ) (STO: VIMAB)

Vimab Group AB Statistics

Total Valuation

Vimab Group AB has a market cap or net worth of SEK 255.78 million. The enterprise value is 391.26 million.

Market Cap	255.78M
Enterprise Value	391.26M

Important Dates

The next estimated earnings date is Thursday, March 13, 2025.

Earnings Date	Mar 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Vimab Group AB has 23.91 million shares outstanding. The number of shares has increased by 12.58% in one year.

Current Share Class	n/a
Shares Outstanding	23.91M
Shares Change (YoY)	+12.58%
Shares Change (QoQ)	+2.78%
Owned by Insiders (%)	9.90%
Owned by Institutions (%)	n/a
Float	12.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.69
PB Ratio	4.20
P/TBV Ratio	n/a
P/FCF Ratio	593.47
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-10.00
EV / Sales	1.11
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	907.80

Financial Position

The company has a current ratio of 0.79, with a Debt / Equity ratio of 2.05.

Current Ratio	0.79
Quick Ratio	0.44
Debt / Equity	2.05
Debt / EBITDA	87.19
Debt / FCF	316.59
Interest Coverage	-3.40

Financial Efficiency

Return on equity (ROE) is -53.67% and return on invested capital (ROIC) is -10.80%.

Return on Equity (ROE)	-53.67%
Return on Assets (ROA)	-6.76%
Return on Invested Capital (ROIC)	-10.80%
Return on Capital Employed (ROCE)	-23.47%
Revenue Per Employee	1.50M
Profits Per Employee	-166,532
Employee Count	170
Asset Turnover	1.15
Inventory Turnover	4.69

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +17.20% in the last 52 weeks. The beta is -0.68, so Vimab Group AB's price volatility has been lower than the market average.

Beta (5Y)	-0.68
52-Week Price Change	+17.20%
50-Day Moving Average	9.76
200-Day Moving Average	9.42
Relative Strength Index (RSI)	47.65
Average Volume (20 Days)	40,179

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vimab Group AB had revenue of SEK 353.19 million and -39.14 million in losses. Loss per share was -1.71.

Revenue	353.19M
Gross Profit	96.23M
Operating Income	-33.35M
Pretax Income	-40.90M
Net Income	-39.14M
EBITDA	1.57M
EBIT	-33.35M
Loss Per Share	-1.71

Balance Sheet

The company has 6.79 million in cash and 136.45 million in debt, giving a net cash position of -129.66 million or -5.42 per share.

Cash & Cash Equivalents	6.79M
Total Debt	136.45M
Net Cash	-129.66M
Net Cash Per Share	-5.42
Equity (Book Value)	66.72M
Book Value Per Share	2.55
Working Capital	-36.26M

Cash Flow

In the last 12 months, operating cash flow was 2.37 million and capital expenditures -1.94 million, giving a free cash flow of 431,000.

Operating Cash Flow	2.37M
Capital Expenditures	-1.94M
Free Cash Flow	431,000
FCF Per Share	0.02

Margins

Gross margin is 27.25%, with operating and profit margins of -9.44% and -11.08%.

Gross Margin	27.25%
Operating Margin	-9.44%
Pretax Margin	-11.58%
Profit Margin	-11.08%
EBITDA Margin	0.44%
EBIT Margin	-9.44%
FCF Margin	0.12%

Dividends & Yields

Vimab Group AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.58%
Shareholder Yield	-12.58%
Earnings Yield	-15.30%
FCF Yield	0.17%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Vimab Group AB has an Altman Z-Score of 0.34. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.34
Piotroski F-Score	n/a